While we provide robust genetic evidence that elevated levels of HYOU1 increase (life-long) CAD risk and demonstrated that prolonged fasting potentially compensates by decreasing plasma levels, the exact mechanism remains to be established. The gene discussed is HYOU1; the disease is coronary artery disorder.